DataMeds AI, Inc. (MEDS) stock
MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.74+0.10 (+15.41%)
Close on Nov 18, 2026Market cap $2.26MP/E –Yield –
DataMeds AI price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
DataMeds AI's price to sales ratio was 0.3× on Nov 11, 2026, against 1.6× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.3× | −0.7 |
| 2025 | Dec 31, 2025 | 1.0× | – |
See a number that looks wrong?